低剂量CT筛查对石棉暴露工人肺癌死亡率的影响
在2433名石棉暴露男性的职业健康监测队列中,比较参加ATOM002研究(LDCT-P,926人)与同期未参加者(LDCT-NP,1507人)的死亡情况。LDCT-P组肺癌死亡率低于地区和全国参照水平,且相比LDCT-NP组肺癌死亡风险显著降低(HR=0.41,95%CI 0.17-0.96)。
要点
- LDCT筛查参与者肺癌死亡风险较未参与者降低(HR=0.41,95%CI 0.17-0.96)。
- LDCT-P组全因死亡率亦降低(HR=0.61,95%CI 0.44-0.84)。
- 全肿瘤与胸膜恶性肿瘤死亡率未见显著降低。
核心结论
- 在本队列中,参加LDCT筛查研究与肺癌死亡率降低相关,支持在石棉暴露工人监测项目中使用LDCT。
研究设计与样本
- 基于2433名石棉暴露男性的职业健康监测队列,比较ATOM002研究参与者(LDCT-P,926人)与同期非参与者(LDCT-NP,1507人)的死亡率。
- 采用Cox比例风险模型比较两组全因、全肿瘤、肺癌及胸膜恶性肿瘤生存,校正年龄、吸烟史、石棉暴露水平和合并症。
- 使用地区和全国率估算LDCT-P与LDCT-NP的标准化死亡比(SMR_FVG与SMR_ITA)。
主要发现
- LDCT-P组肺癌死亡率低于地区与全国参照(SMR_FVG=0.55,95%CI 0.24-1.09;SMR_ITA=0.51,95%CI 0.22-1.01)。
- LDCT-NP组未见类似降低(SMR_FVG=2.07,95%CI 1.53-2.73;SMR_ITA=1.98,95%CI 1.47-2.61)。
- LDCT-P相比LDCT-NP肺癌死亡风险降低(HR=0.41,95%CI 0.17-0.96),全因死亡亦降低(HR=0.61,95%CI 0.44-0.84)。
- 全肿瘤死亡(HR=0.97,95%CI 0.62-1.50)与胸膜恶性肿瘤死亡(HR=0.86,95%CI 0.31-2.41)未见显著降低。
临床怎么用
- 对石棉暴露工人的职业健康监测可考虑纳入LDCT肺癌筛查,并关注全因死亡风险变化。
- 解读效果时应结合地区与全国参照的标准化死亡比及与未筛查者的风险比。
局限性
- 为队列内参与者与非参与者的比较,非随机设计,可能存在选择偏倚等混杂。
- 肺癌死亡率的标准化死亡比置信区间包含1,且研究限于石棉暴露男性人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We previously showed that low-dose computed tomography (LDCT) screening in asbestos-exposed workers is effective in detecting lung cancer (LC) at an early stage. Here, we evaluate whether LDCT screening could reduce mortality from LC in such a high-risk population. METHODS: Within a cohort of 2433 asbestos-exposed men enrolled in an Occupational Health surveillance programme, we compared mortality between the participants in the ATOM002 study (LDCT-P, N = 926) and contemporary non-participants (LDCT-NP, N = 1507). We estimated standardized mortality ratios for the LDCT-P and LDCT-NP populations using regional and national rates (SMR_FVG and SMR_ITA, respectively). We compared survival for all causes, all neoplasms, LC and malignant neoplasm of pleura (MNP) between LDCT-P and LDCT-NP using Cox proportional hazard models adjusted for age, smoking history, asbestos exposure level and comorbidities. RESULTS: A reduction in mortality from LC was observed in the LDCT-P group compared with regional and national figures (SMR_FVG = 0.55, 95% confidence interval (CI) 0.24-1.09; SMR_ITA = 0.51, 95% CI 0.22-1.01); this was not the case for the LDCT-NP group (SMR_FVG = 2.07, 95% CI 1.53-2.73; SMR_ITA = 1.98, 95% CI 1.47-2.61). A strong reduction in LC mortality was observed for the LDCT-P compared with the LDCT-NP [hazard ratio (HR) = 0.41, 95% CI 0.17-0.96]. Mortality was also reduced for all causes (HR = 0.61, 95% CI 0.44-0.84), but not for all neoplasms (HR = 0.97, 95% CI 0.62-1.50) and MNP (HR = 0.86, 95% CI 0.31-2.41) within the LDCT-P population. CONCLUSIONS: In our cohort, participation in the LDCT screening study was associated with reduced mortality from LC. This finding supports the use of LDCT in surveillance programmes for asbestos-exposed workers.
引用
- Barbone F, Barbiero F, Belvedere O, et al. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers. Int J Epidemiol. 2018. PMID: 30325420. doi:10.1093/ije/dyy212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。